(S)-methyl 6-(3-(1-(3-methoxyphenyl)ethyl)ureido)-4-oxo-1,4-dihydroquinoline-2-carboxylate

ID: ALA4208917

PubChem CID: 145965856

Max Phase: Preclinical

Molecular Formula: C21H21N3O5

Molecular Weight: 395.42

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)c1cc(=O)c2cc(NC(=O)N[C@@H](C)c3cccc(OC)c3)ccc2[nH]1

Standard InChI:  InChI=1S/C21H21N3O5/c1-12(13-5-4-6-15(9-13)28-2)22-21(27)23-14-7-8-17-16(10-14)19(25)11-18(24-17)20(26)29-3/h4-12H,1-3H3,(H,24,25)(H2,22,23,27)/t12-/m0/s1

Standard InChI Key:  PZFGBNDEOVAVFQ-LBPRGKRZSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   37.8962  -26.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7302  -26.1501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7291  -26.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4371  -27.3786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4353  -25.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1439  -26.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1473  -26.9671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8557  -27.3723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.5654  -26.9613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.5620  -26.1407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8490  -25.7310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.8580  -28.1895    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.2685  -25.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.2659  -24.9127    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.9774  -26.1363    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.9800  -26.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0210  -27.3777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.3136  -26.9685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3143  -26.1513    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.6056  -27.3765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.8959  -26.1501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1887  -27.3762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4826  -26.9630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7756  -27.3712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7754  -28.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4882  -28.5974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1924  -28.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0679  -26.9625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0680  -26.1453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  6 11  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  8 12  2  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
  3 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20  1  1  0
  1 21  1  6
  1 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 24 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4208917

    ---

Associated Targets(Human)

KOPN-8 (317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SEM (217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SUP-B15 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UoC-B1 (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THLE-2 (239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.42Molecular Weight (Monoisotopic): 395.1481AlogP: 3.21#Rotatable Bonds: 5
Polar Surface Area: 109.52Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.79CX Basic pKa: CX LogP: 3.07CX LogD: 3.07
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.57Np Likeness Score: -1.25

References

1. Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F..  (2018)  Novel vitexin-inspired scaffold against leukemia.,  146  [PMID:29407975] [10.1016/j.ejmech.2018.01.004]

Source